首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1477915

新生儿筛检市场- 按产品类型（仪器、消耗品）、技术（串联质谱、血氧测定、酶检测、DNA 检测）、测试类型（干血斑、听力筛检、CCHD）、最终用途- 全球预测、 2024 - 2032

Newborn Screening Market - By Product Type (Instruments, Consumables), Technology (Tandem Mass Spectrometry, Oximetry, Enzyme-Based Assays, DNA Assays), Test Type (Dried Blood Spot, Hearing Screening, CCHD), End-use - Global Forecast, 2024 - 2032

出版日期: 2024年02月22日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

受政府加强早期疾病检测倡议、医疗保健专业人员和家长意识不断增强以及新生儿筛检测试对高品质耗材需求不断增长的推动，全球新生儿筛检市场规模在2024 年至2032 年期间将以7.7 % 的复合年增长率成长。

据世界卫生组织称，随着新生儿和 5 岁以下儿童死亡率的下降，先天性疾病在这些死亡中所占的比例越来越大。随着全球越来越多的婴儿出生时患有先天性疾病，迫切需要早期发现和干预，以减轻对其健康和福祉的潜在影响。

这些疾病涵盖范围广泛，从代谢紊乱到先天性心臟缺陷、脊髓性肌肉萎缩和各种遗传异常。随着人们越来越认识到早期诊断对于改善临床结果和降低医疗成本的重要性，医疗保健系统正在将更多资源投入到新生儿筛检计画中，导致对筛检测试和相关服务的需求激增。

新生儿筛检市场根据产品类型、技术、测试类型、最终用途和地区进行分类。

由于消耗品在新生儿筛检过程中发挥关键作用，因此消耗品细分市场将在 2024 年至 2032 年间大幅成长，涵盖采血设备、试剂和检测试剂盒等一系列产品。随着全球新生儿筛检测试数量的不断增加，对高品质耗材的需求不断增长，以确保结果准确可靠。新生儿筛检市场的製造商正在专注于开发创新耗材，以提高检测效率，同时保持严格的品质标准。此外，干血斑（DBS）技术的出现简化了样本采集和运输，从而促进了细分市场的成长。

到2032 年，血氧测定领域的新生儿筛检市场份额将获得显着增长，因为脉搏血氧计通常用于筛检新生儿先天性心臟病和其他呼吸系统疾病，从而实现早期发现和及时干预。将血氧测定法纳入新生儿筛检方案提高了危重先天性心臟病 (CCHD) 的检出率，从而改善临床结果并降低医疗成本。此外，随着医疗机构升级其筛检基础设施，预计细分市场将进一步成长。

由于该地区对预防性医疗保健的日益重视和遗传性疾病盛行率的不断上升，亚太地区新生儿筛检产业将在 2032 年呈现出可观的成长速度。中国、印度和日本等国政府旨在扩大新生儿筛检计画和改善医疗基础设施的措施激增。此外，医疗保健支出的增加以及家长对早期疾病检测重要性的认识不断提高，正在推动该地区的市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 遗传和代谢疾病的发生率增加
  - 技术进步
  - 医疗保健专业人员和家长的意识不断提高
  - 出生率上升和人口成长
- 产业陷阱与挑战
  - 世界各地新生儿筛检程序缺乏统一性
  - 严格的监理政策
成长潜力分析
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

主要趋势
仪器
- 干血点打孔器
- 听力筛检设备
- 分析仪
- 电泳装置
- 脉搏血氧仪
- 其他仪器
耗材

第 6 章：市场估计与预测：按技术划分，2018 年 - 2032 年

主要趋势
串联质谱法
血氧测定法
基于酵素的测定
DNA检测
其他技术

第 7 章：市场估计与预测：按测试类型，2018 - 2032

主要趋势
干血斑
听力筛检
严重先天性心臟病（CCHD）
其他测试类型

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

主要趋势
医院
诊断中心
其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Masimo Corporation
Medtronic plc
Natus Medical Incorporated
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Waters Corporation

简介目录

Product Code: 8223

Global Newborn Screening Market Size will grow at 7.7% CAGR during 2024-2032, driven by increasing government initiatives for early disease detection, growing awareness among healthcare professionals and parents, and rising demand for high-quality consumables in newborn screening tests.

According to WHO, as neonatal and under-5 mortality rates decrease, congenital disorders represent a growing proportion of these deaths. With an increasing number of infants being born with congenital conditions globally, there's a pressing need for early detection and intervention to mitigate the potential impact on their health and well-being.

These disorders encompass a wide spectrum, ranging from metabolic disorders to congenital heart defects, spinal muscular atrophy, and various genetic abnormalities. As awareness grows regarding the significance of early diagnosis in improving clinical outcomes and reducing healthcare costs, healthcare systems are investing more resources into newborn screening programs, resulting in a surge in demand for screening tests and related services.

The Newborn Screening Market is classified based on product type, technology, test type, end-use, and region.

Consumables segment will grow substantially between 2024 and 2032, owing to their pivotal role in the newborn screening process, encompassing a range of products such as blood collection devices, reagents, and assay kits. With the increasing volume of newborn screening tests conducted globally, there is a growing demand for high-quality consumables to ensure accurate and reliable results. Manufacturers in the newborn screening market are focusing on developing innovative consumables that enhance testing efficiency while maintaining stringent quality standards. Furthermore, the advent of dried blood spot (DBS) technology has simplified sample collection and transportation, thereby inducing segment growth.

The Newborn Screening Market Share from the oximetry segment will garner noticeable gains through 2032, as pulse oximeters are commonly used to screen for congenital heart defects and other respiratory conditions in newborns, enabling early detection and timely intervention. The integration of oximetry into newborn screening protocols has improved the detection rate of critical congenital heart diseases (CCHD), leading to better clinical outcomes and reduced healthcare costs. Moreover, as healthcare facilities upgrade their screening infrastructure, further segment growth is anticipated.

Asia Pacific Newborn Screening Industry will exhibit a decent growth rate through 2032, driven by the increasing emphasis on preventive healthcare and the growing prevalence of genetic disorders in the region. Countries such as China, India, and Japan are witnessing a surge in government initiatives aimed at expanding newborn screening programs and improving healthcare infrastructure. Moreover, rising healthcare expenditure and greater awareness among parents regarding the importance of early disease detection are fueling market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing incidence of genetic and metabolic disorders
  - 3.2.1.2 Advancements in technology
  - 3.2.1.3 Rising awareness among healthcare professionals and parents
  - 3.2.1.4 Rising birth rates and population growth
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of uniformity of newborn screening procedure around the world
  - 3.2.2.2 Stringent regulatory polices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
- 5.2.1 Dried blood spot puncher
- 5.2.2 Hearing screening devices
- 5.2.3 Analyzers
- 5.2.4 Electrophoresis unit
- 5.2.5 Pulse oximetry
- 5.2.6 Other instruments
5.3 Consumables

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Tandem mass spectrometry
6.3 Oximetry
6.4 Enzyme-based assays
6.5 DNA assays
6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Dried blood spot
7.3 Hearing screening
7.4 Critical congenital heart defect (CCHD)
7.5 Other test types

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic centers
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa